Meghmani Organics Limited — Investor Meet, 04-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Meghmani Organics' Q1 FY26 standalone revenue jumped 44% to INR 593 Cr, with EBITDA up six-fold to INR 81 Cr and PAT at INR 40 Cr, reversing a previous loss. Consolidated revenue also rose 48% to INR 614 Cr. This strong performance reflects improved product mix, stable raw material costs, and recovering demand. Management is optimistic, targeting double-digit growth in Crop Protection for the next three years, fueled by new, high-value products and global market registrations. They expect Titanium Dioxide to see improved pricing and utilization from Q3 FY26 as anti-dumping duties take full effect. The company is focused on debt reduction and maintaining double-digit EBITDA margins.